Open Access
Sodium Nitrite-Mediated Killing of the Major Cystic Fibrosis Pathogens Pseudomonas aeruginosa , Staphylococcus aureus , and Burkholderia cepacia under Anaerobic Planktonic and Biofilm Conditions
Author(s) -
Tiffany A. Major,
Warunya Panmanee,
Joel E. Mortensen,
Laura Gray,
Niel C. Hoglen,
Daniel J. Hassett
Publication year - 2010
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00379-10
Subject(s) - pseudomonas aeruginosa , microbiology and biotechnology , staphylococcus aureus , burkholderia , cystic fibrosis , biology , burkholderia cenocepacia , biofilm , antibiotics , burkholderia cepacia complex , pathogen , methicillin resistant staphylococcus aureus , bacteria , genetics
A hallmark of airways in patients with cystic fibrosis (CF) is highly refractory, chronic infections by several opportunistic bacterial pathogens. A recent study demonstrated that acidified sodium nitrite (A-NO2 − ) killed the highly refractory mucoid form ofPseudomonas aeruginosa , a pathogen that significantly compromises lung function in CF patients (S. S. Yoon et al., J. Clin. Invest.116: 436-446, 2006). Therefore, the microbicidal activity of A-NO2 − (pH 6.5) against the following three major CF pathogens was assessed:P. aeruginosa (a mucoid,mucA22 mutant and a sequenced nonmucoid strain, PAO1),Staphylococcus aureus USA300 (methicillin resistant), andBurkholderia cepacia , a notoriously antibiotic-resistant organism. Under planktonic, anaerobic conditions, growth of all strains except forP. aeruginosa PAO1 was inhibited by 7.24 mM (512 μg ml−1 NO2 − ).B. cepacia was particularly sensitive to low concentrations of A-NO2 − (1.81 mM) under planktonic conditions. In antibiotic-resistant communities known as biofilms, which are reminiscent of end-stage CF airway disease, A-NO2 − killed mucoidP. aeruginosa ,S. aureus , andB. cepacia ; 1 to 2 logs of cells were killed after a 2-day incubation with a single dose of ∼15 mM A-NO2 − . Animal toxicology and phase I human trials indicate that these bactericidal levels of A-NO2 − can be easily attained by aerosolization. Thus, in summary, we demonstrate that A-NO2 − is very effective at killing these important CF pathogens and could be effective in other infectious settings, particularly under anaerobic conditions where bacterial defenses against the reduction product of A-NO2 − , nitric oxide (NO), are dramatically reduced.